Emily Mullin: But like any medical device company, Neuralink will need to prove a medical case to the FDA to get its product to market. So yeah, there's what Elon Musk says, and then there's sort of the reality of getting a product to market. I don't think Synchron sees its technology in that way, but I think like Synchron, Neuralink is first focusing on restoring digital autonomy to people with severe physical disabilities. There were four initial patients in Australia and six in the US that got the Synchron BCI, and they followed those patients for a year after implantation. With the Synchron device it's more about the possibility of blood clots or blocking a blood vessel.